343 related articles for article (PubMed ID: 9267983)
1. Fatty acid induced insulin resistance in rat-1 fibroblasts overexpressing human insulin receptors: impaired insulin-stimulated mitogen-activated protein kinase activity.
Usui I; Takata Y; Imamura T; Morioka H; Sasaoka T; Sawa T; Ishihara H; Ishiki M; Kobayashi M
Diabetologia; 1997 Aug; 40(8):894-901. PubMed ID: 9267983
[TBL] [Abstract][Full Text] [Related]
2. The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor.
Calleja V; Ruiz EnrĂquez P; Filloux C; Peraldi P; Baron V; Van Obberghen E
Endocrinology; 1997 Mar; 138(3):1111-20. PubMed ID: 9048617
[TBL] [Abstract][Full Text] [Related]
3. Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors.
Inoue G; Cheatham B; Kahn CR
J Biol Chem; 1996 Nov; 271(45):28206-11. PubMed ID: 8910437
[TBL] [Abstract][Full Text] [Related]
4. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
[TBL] [Abstract][Full Text] [Related]
5. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
6. Pertussis toxin-sensitive and insensitive intracellular signalling pathways in undifferentiated 3T3-L1 cells stimulated by insulin converge with phosphatidylinositol 3-kinase upstream of the Ras mitogen-activated protein kinase cascade.
Uehara T; Tokumitsu Y; Nomura Y
Eur J Biochem; 1999 Feb; 259(3):801-8. PubMed ID: 10092867
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control.
Parpal S; Karlsson M; Thorn H; StrÄlfors P
J Biol Chem; 2001 Mar; 276(13):9670-8. PubMed ID: 11121405
[TBL] [Abstract][Full Text] [Related]
8. Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Takata Y; Imamura T; Usui I; Langlois WJ; Sawa T; Kobayashi M
J Biol Chem; 1997 Apr; 272(14):9581-6. PubMed ID: 9083103
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins.
Solow BT; Harada S; Goldstein BJ; Smith JA; White MF; Jarett L
Mol Endocrinol; 1999 Oct; 13(10):1784-98. PubMed ID: 10517679
[TBL] [Abstract][Full Text] [Related]
10. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
Thirone AC; Carvalho CR; Saad MJ
Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
[TBL] [Abstract][Full Text] [Related]
12. Relative involvement of Shc tyrosine 239/240 and tyrosine 317 on insulin induced mitogenic signaling in rat1 fibroblasts expressing insulin receptors.
Ishihara H; Sasaoka T; Wada T; Ishiki M; Haruta T; Usui I; Iwata M; Takano A; Uno T; Ueno E; Kobayashi M
Biochem Biophys Res Commun; 1998 Nov; 252(1):139-44. PubMed ID: 9813159
[TBL] [Abstract][Full Text] [Related]
13. UV activation of receptor tyrosine kinase activity.
Coffer PJ; Burgering BM; Peppelenbosch MP; Bos JL; Kruijer W
Oncogene; 1995 Aug; 11(3):561-9. PubMed ID: 7543196
[TBL] [Abstract][Full Text] [Related]
14. Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart.
Laviola L; Belsanti G; Davalli AM; Napoli R; Perrini S; Weir GC; Giorgino R; Giorgino F
Diabetes; 2001 Dec; 50(12):2709-20. PubMed ID: 11723053
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
Kim B; Leventhal PS; White MF; Feldman EL
Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
[TBL] [Abstract][Full Text] [Related]
16. Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors.
Daulhac L; Kowalski-Chauvel A; Pradayrol L; Vaysse N; Seva C
J Biol Chem; 1999 Jul; 274(29):20657-63. PubMed ID: 10400698
[TBL] [Abstract][Full Text] [Related]
17. Effect of nutritional state on the formation of a complex involving insulin receptor IRS-1, the 52 kDa Src homology/collagen protein (Shc) isoform and phosphatidylinositol 3'-kinase activity.
Dupont J; Derouet M; Simon J; Taouis M
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):293-300. PubMed ID: 9761726
[TBL] [Abstract][Full Text] [Related]
18. G protein beta gamma subunits stimulate phosphorylation of Shc adapter protein.
Touhara K; Hawes BE; van Biesen T; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9284-7. PubMed ID: 7568118
[TBL] [Abstract][Full Text] [Related]
19. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE
Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]